Investors including co-founder and Harvard professor Timothy Springer scored exits as mRNA therapy developer Moderna floated in the largest biotech IPO of all time.
Moderna, a US-based messenger RNA (mRNA) therapeutics developer exploiting research conducted at Harvard University, raised approximately $604m in its initial public offering last Friday.
The IPO, the largest ever for a biotech company, consisted of almost 26.3 million shares issued on the Nasdaq Global Select Market priced at $23.00 each, up from 21.7 million shares when it set a $22 to $24 range late last month. The offering valued it at approximately $7.52bn.
Moderna is working…
